Allogeneic Transplantation
Non-Cancerous Blood Disorder Trials
COMIRB: 25-1303
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia (advance NEXT)
Principal Investigator: Gemlyn George
The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP).
COMIRB: 24-2052
Phase 3 Study of Bomedemstat (MK-3543/IMG-7289) v. Best Available
PI: Brandon McMahon
Essential thrombocythemia who have an inadequate response to or are intolerant of hydroxyurea
COMIRB: 23-1265
A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
PI: Gemlyn George
Eligibility: Ages ≥ 18; Recent unfractionated heparin or low-molecular-weight heparin exposure
Request an Appointment
If you would like to schedule an appointment, please give us a call.
Our intake coordinator will help you navigate the process of becoming a new patient including helping you obtain the necessary referrals, get the necessary medical records transferred, and coordinate care with your existing physicians. We are available to answer your questions about our clinic, your treatment, and participation in ongoing clinical trials.